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Adenosine-to-inosine (A-to-I) editing modifies RNA transcripts from their genomic blueprint. A prerequisite for this
process is a double-stranded RNA (dsRNA) structure. Such dsRNAs are formed as part of the microRNA (miRNA)
maturation process, and it is therefore expected that miRNAs are affected by A-to-I editing. Editing of miRNAs has the
potential to add another layer of complexity to gene regulation pathways, especially if editing occurs within the miRNA–
mRNA recognition site. Thus, it is of interest to study the extent of this phenomenon. Current reports in the literature
disagree on its extent; while some reports claim that it may be widespread, others deem the reported events as rare.
Utilizing a next-generation sequencing (NGS) approach supplemented by an extensive bioinformatic analysis, we were
able to systematically identify A-to-I editing events in mature miRNAs derived from human brain tissues. Our algorithm
successfully identified many of the known editing sites in mature miRNAs and revealed 17 novel human sites, 12 of which
are in the recognition sites of the miRNAs. We confirmed most of the editing events using in vitro ADAR overexpression
assays. The editing efficiency of most sites identified is very low. Similar results are obtained for publicly available data sets
of mouse brain-regions tissues. Thus, we find that A-to-I editing does alter several miRNAs, but it is not widespread.
[Supplemental material is available for this article.]
A-to-I editing is catalyzed by enzymes of the adenosine deaminase
that act on the RNA (ADAR) family, and post-transcriptionally
changes adenosine to inosine, the latter being treated by cell ma-
chinery similar to guanosine. This modification results in protein
recoding of tens of genes (Nishikura 2010), shown in some cases to
translate to modified biophysiological properties with critical im-
plication on brain function (Sommer et al. 1991). However, only
a minute fraction of A-to-I modifications results in protein recod-
ing, whereas most targets of ADARs reside within the noncoding
parts of the transcriptome (Li et al. 2009; Nishikura 2010).
The primary transcript of a miRNA gene (pri-miRNA) folds
into a hairpin structure and undergoes cleavage by the nuclear en-
zyme Drosha, giving a 60- to 70-nucleotide (nt) precursor miRNA
(pre-miRNA). The pre-miRNA is exported from the nucleus by
Exportin-5 andprocessed by the cytoplasmtic enzymeDicer into 19-
to 25-nt imperfect double-stranded RNA (dsRNA) (Bartel 2004). One
or both strands of the duplex may serve as the functional mature
miRNA. By binding to partially complementary targets located in
the 39 untranslated region of specificmRNAs,maturemiRNAs block
the translation or guide the degradation of target mRNAs. Bases 2–8
at the 59 end of the mature miRNA were found to be critical for the
target recognition (Bartel 2004). By regulating protein expression,
miRNAs are involved in many cellular and physiological processes,
includingnumerous pathological conditions (Chang et al. 2008). As
ADARs binds to dsRNA, they may act on the double-strand forma-
tion of pri-miRNA (Yang et al. 2006). A-to-I editing of pri-miRNA can
affect the processing of the pri-miRNA to pre-miRNA or the pro-
cessing of the pre-miRNA to mature miRNA (Yang et al. 2006).
Pri-miRNA editing eventsmay lead to the expression of edited
maturemiRNAs. If the alterations are in the recognition site, knownas
the ‘‘seed’’ region, a change in the target genes is expected. A striking
example is mouse miR-376, in which editing in the recognition site
alters the target specificity of the miRNA and profoundly affects cel-
lular processes (Kawahara et al. 2007). A-to-I editing events that
change target specificity of miRNAs clearly add another layer of
complexity to gene regulation pathways. It is therefore of interest to
study the extent of this phenomenon. Initial reports, based on low-
throughput experiments, estimated that it may be widespread
(Kawahara et al. 2008). Proper utilization of next-generation se-
quencing (NGS) has the potential to unravel the full extent of A-to-I
editing in miRNAs. Unfortunately, so far NGS-based experiments
resulted in puzzling results; many types of DNA-to-readsmismatches,
including adenosine-to-guanosine (A-to-G) (which may be caused by
A-to-I editing), were detected (Landgraf et al. 2007; Morin et al. 2008;
Ebhardt et al. 2009; Martı´ et al. 2010; Pantano et al. 2010; Joyce et al.
2011). These findings could mean that miRNAs undergomany kinds
of biological modifications, including A-to-I editing. However,
one must also consider technical explanations for the variety of
mismatches observed. Indeed, de Hoon et al. (2010) have reported
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technical problems in the analysis of NGS
data sets that may result in false detection
of miRNA modification events. They have
concluded that the editing events in ma-
ture miRNAs are rare (de Hoon et al. 2010).
Here we set out to comprehensively iden-
tify A-to-I editing in mature miRNAs using
NGS followed by bioinformatics analysis.
In contrast to previous reports, we find a
clear A-to-I signal in mature miRNAs.
This work focuses on human brain
tissue for two main reasons: The first is
the obvious importance of unraveling
the scope of mature miRNAs editing in
this tissue, and second is the strong line
of evidence pointing toward high A-to-I
editing in human brain compared with
other organismsand tissues (Eisenberg et al.
2005; Paz-Yaacov et al. 2010).
Results
Sequencing of miRNAs from human
brain tissue
Sequencing of maturemiRNAs has the po-
tential to unravel many kinds of sequence
modifications, including A-to-I editing, as
inosine (I) in the RNA leads to a guanosine
(G) in the sequencing output. Mature
miRNAs from human brain tissue (FirstChoice human brain ref-
erence RNA, Ambion) were sequenced using one lane of Illumina
GAIIx instrument (Methods). The following considerations were
taken into account in the sequencing data analysis: (1) The 39 end
of mature miRNAs undergoes large-scale RNAmodifications in the
form of adenylation and uridylation (Burroughs et al. 2010).
Therefore, the last two bases of the sequencing read, which cor-
respond to the 39 end of thematuremiRNA,were trimmed (Chiang
et al. 2010). (2) As demonstrated by de Hoon et al. (2010), cross-
mapping of sequencing reads can create many false alignments
that may be interpreted as sequence alterations. Therefore, we
have aligned all the trimmed reads against the human genome
using Bowtie (Langmead et al. 2009), demanding unique best hits
with up to one mismatch (Methods). Only reads that were aligned
to the genomic locations of known miRNAs were further used. (3)
Sequencing error hinders the discovery of editing sites. Thus, we
filtered mismatches with low-quality score. Then, the sequencing
error rate was estimated, and only sites with significant modifica-
tion, as determined by binomial cumulative distribution, were
recorded (Methods). (4) Known single nucleotide polymorphisms
(SNPs) sites were removed using the dbSNP data set (Sherry et al.
2001). The detection procedure is illustrated in Figure 1 (also see
Methods).
A clear A-to-I editing signal in human brain miRNAs
Overall, 19 statistically significantmodification sites were detected
in 18 different miRNAs expressed in this sample (Table 1). Re-
markably, all of them were A-to-G modifications, suggesting that
they represent A-to-I editing rather than random sequencing or
alignment errors (Methods; Fig. 1; Levanon et al. 2004). Another
indication for the observed modifications being editing sites comes
from analysis of the sequence and structural motifs. As expected for
true A-to-I editing sites (Kleinberger and Eisenberg 2010), we find
enrichment of uridine (U) and depletion of G in the upstream nu-
cleotide position (12 U and zero G out of 19 sites). The nucleotide
opposing the editing site is typically cytidine (C) orU (17/19), andG
is overrepresented in the downstream nucleotide (eight of 19).
These sequence motifs are in accordance with the expected prop-
erties of true A-to-I editing sites (Fig. 2; Supplemental Tables 1, 2).
About half of the detectedmodifications are supported by the
literature, again pointing to the validity of the list (Table 1).
Moreover, out of the 12 experimentally validated and documented
editing sites in mature human miRNAs that were expressed in our
sample, six were identified (Methods; Supplemental Table 3), in-
dicating a satisfactory (but not perfect) detection power. It is also of
interest to compare our results with a recent report of editing in
maturemiRNAs from themouse brain (Chiang et al. 2010). Editing
in eight out of the 19 sites is conserved between the mouse and
human, including sites with relatively low editing levels (Table 1).
Surprisingly, the editing levels of human and mouse miRNAs are
comparable, and in some cases, the editing levels are in fact higher
in the mouse. This finding contrasts an earlier NGS-based report
claiming that editing in mature miRNAs is less common in mice
than in humans (Landgraf et al. 2007). This disagreementmight be
attributed to themany sequencemodifications (other thanA-to-G)
observed in the previous report (Landgraf et al. 2007), suggesting
a higher false-positive rate.
In vitro overexpression experiments validate the in vivo data
The clear editing signal observed makes it reasonable to assume
that the novel A-to-Gmodification sites identified are due to A-to-I
editing. Nevertheless, we sought for direct validation of the pos-
Figure 1. A schematic representation of the procedure for identifying editing sites in mature miRNAs
using the brain sample data (for details, see Methods). In each one of the four steps (A–D), the total
number of mismatches of any type is given in absolute numbers (bar chart) and in relative proportions
(pie chart). (A) If the untrimmed reads are aligned against the known miRNA sequences, a strong signal
of adenylation and uridylation is observed. (B) After trimming the 39 end of the reads, A-to-G modifi-
cations become dominant. (C ) If the trimmed reads are aligned against the genome and not directly
against the miRNA sequences, the relative proportion of the A-to-G mismatches is enhanced as a result
of less cross-mapping. (D) After possible sequencing errors are removed by using binomial statistics, only
A-to-G modifications are observed.
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sibly novel editing sites. We note that direct Sanger sequencing is
inefficient for this task, due to editing levels being too low to be
detected (<2%) or miRNA in question being weakly expressed. A
primer extension assay might be able to differentiate changes in
the relative ratios of edited and nonedited microRNA species.
However, we have taken a more global approach and tested the
effect of ADAR and ADARB1 (also known as ADAR1 and ADAR2,
respectively) overexpression on the full miRNA editing profile in
human brain–originated U87 glioblastoma cell-line. Knockdown
experiments were not considered, due to the low editing levels in
this cell-line compared with the levels in brain tissues (Paz et al.
2007). We have used Illumina’s HiSeq2000 apparatus to perform
NGS of miRNAs from the control U87 cell-line and compared the
results to the ADAR and ADARB1 overexpression (Methods). We
hypothesized that someof themiRNAs thatwere detected as edited
in the brain tissue sequencing will also be detected as edited in the
cell-line overexpression experiments, if they are indeed expressed in
this cell-line. Overall, out of 18 miRNAs detected as being edited in
the brain tissue 12 miRNAs were expressed in the U87 cell-line. Im-
portantly, a third were indeed validated as ADAR or ADARB1 editing
targets in the cell-line overexpression experiments (Methods; Table
1), most of which were found to be ADARB1-dependent.
As ADARB1 overexpression seems to have a larger effect on
miRNA editing comparedwith ADAR in the U87 cell-line (Table 1),
we have repeated the ADARB1 overexpression experiment. This
time we used a different human brain–originated cell-line, the
U118 glioblastoma, and employed a stable ADARB1 transfection
assay (Methods). Illumina’sHiSeq2000 apparatuswas again used to
performNGSofmiRNAs from control andADARB1 overexpressing
U118 cell-lines (Methods). Strikingly, all the detected editing sites
in the U87 were also detected in the U118, demonstrating the ro-
bustness of our detection procedure. Three and 13 additional
mature miRNAs editing sites were identified in the U87 and the
U118 experiments, respectively, bringing the total number of
detected editing events in mature miRNAs to over 30 (Methods;
Supplemental Table 5). Note, however, that the sites detected only
in the cell-line overexpression samples should be treated with
caution as they may not be edited in human physiological con-
ditions. The validation process, for four novel human editing sites,
is illustrated in Figure 3.
A-to-I editing in miRNAs from the frontal lobe of individuals
As the human brain tissue described above was a pool of different
brain regions from multiple donors, it is of interest to examine the
profile of miRNA editing in a specific brain region of a single in-
dividual. Therefore, Illumina’s HiSeq2000 apparatus was used to
perform NGS of miRNAs from the frontal lobe of two individuals
(Methods). Again, a clearA-to-I editing signalwas observed (Methods).
Fourteen statistically significant A-to-G modification sites were
Table 1. The statistically significant A-to-G modifications sites detected in mature miRNAs using the pooled human brain sample and the
human frontal lobe samples
miRNA Location P-valuea
Editing levels
in pooled
human
brain
Editing levels
in human
frontal lobe,
sample A
Editing levels
in human
frontal lobe,
sample B
Editing
levels in U87
control/ADAR
/ADARB1
Editing levels
in U118
control/
ADARB1
Editing levels
in mouse
brainb
let-7d Star position 5 7 3 1010 1.2 0.7 N.S. N.S. N.S.
let-7e Star position 5 9 3 105 N.S. 1.7 N.S. N.S. N.S.
miR-27a Mature position 6 5 3 1012 1.2 2.3 N.S. N.S. N.S.
miR-27b Mature position 4 1 3 1012 0.4 N.S. N.S. N.S. N.S.
miR-99a Mature position 1c <1 3 1016 5 1.2 1.4 0/0/0.8 0/17.3
miR-130a Mature position 2 2 3 1011 0.7 N.S. N.S. N.S. 0/0.5
miR-151 3p mature position 3d 3 3 1013e N.S. 0.6 1.7 N.S. 0.1/0.5 0.6–2.5g
miR-200b Mature position 5 5 3 106e N.S. 4.2 N.S. N.E. 0/7.3
miR-340 Star position 13 2 3 109 1.9 N.S. N.S. N.E. N.S.
miR-376b Mature position 6d 8 3 1011 1.5 N.E. N.E. N.E. N.E. 50.1
miR-376b Mature position 13 1 3 1014 1.8 N.E. N.E. N.E. N.E.
miR-376c Mature position 6d <1 3 1016 8.5 N.S. N.S. N.E. N.E. 31.1
miR-376a-1 Star position 3d <1 3 1016 18.9 N.S. N.S. N.E. N.E. 29.7
miR-379 Mature position 5d <1 3 1016 10.2 14.3 N.S. N.E. N.E. 9.5
miR-381 Mature position 4 <1 3 1016 6.3 3.3 1.7 0.6/3.5/0 N.E. 12.5
miR-411 Mature position 5d < 3 1016 15.3 13.9 6.3 N.S. N.E. 23.9
miR-421 Mature position 7 2 3 107f N.S. N.S. 0.7 N.S. N.S.
miR-421 Mature position 14 1 3 105 1.8 1.0 0.9 0/0.4/1.1 0.5/16.9 5.4
miR-455 5p mature position 17 9 3 1015 1.2 N.S. N.S. 0/0.4/3.2 0/19.2
miR-497 Mature position 2 <1 3 1016 6.2 N.S. 2.7 N.S. 0/26.8 10.4
miR-539 Mature position 10 2 3 108 6.7 N.S. N.S. N.E. N.E.
miR-589 Star position 6 <1 3 1016 70 74.1 N.E 1.9/0.4/1.4 0/9.5
miR-598 Mature position 2 2 3 105 0.2 N.S. N.S. N.S. N.S.
miR-641 Mature position 3 1 3 105e N.S. 3.6 13.5 N.S. N.S.
The editing levels in the in vitro ADAR overexpression experiments are also presented. The statistically significant modifications, as detected by our
analysis, are marked with bold. Sites in which the modifications were not statistically significant are marked by N.S. Note that frontal lobe sample B data
set consists of about half the number of reads of sample A, leading to lower statistical detection power. Sites in miRNAs with low expression levels (10 or
fewer reads) are marked with N.E. The editing levels are given in percentage.
aRaw P-value, that is, 1 minus the binomial cumulative distribution function, in the pooled human brain sample.
bChiang et al. (2010).
cKnown editing site (Blow et al. 2006).
dKnown editing site (Kawahara et al. 2008).
eRaw P-value in the human frontal lobe, sample A.
fRaw P-value in the human frontal lobe, sample B.
gDetected in publicly available NGS of mouse brain tissues (Table 2).
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identified in these two samples, nine of which were also identified
in the pooled human brain tissue (Table 1). Out of the five addi-
tional sites observed, two were confirmed as editing sites in the
ADAR overexpression samples (Table 1). Taken together, the total
number of editing sites found in this work for the human brain
under physiological conditions adds up to 24. Editing levels in the
frontal lobe were consistent between the two individuals and be-
tween them and the pooled brain tissue (Table 1). The consistency
across individual samples supports the notion that miRNA editing
could be utilized functionally (Greenberger et al. 2010). Obviously,
more experiments are needed to validate this point.
Possible functional significance of the edited miRNAs
Many of the detected A-to-Gmodifications were at the recognition
site of thematuremiRNAs (Table 1). As demonstrated by Kawahara
et al. (2007), an editing event that changes the binding specificity
of themiRNAmayhave large impact on cellular processes.We used
TargetScan (Lewis et al. 2005) to estimate the effect of the recog-
nition site editing on the miRNA binding specificity (Methods;
Supplemental Table 6). The overlap between the putative mRNA
targets before and after the editing is very small (;3% overlap
on average) (see two examples in Fig. 3), meaning that editing
significantly changes the binding specificity of the miRNAs.
Therefore, it is possible that editing events create, de facto, ‘‘new
miRNAs’’ in the sense that they have new sets ofmRNA targets. It is
tempting to speculate that the newmRNA targets have a common
functional role. Indeed, functional analysis revealed that some
molecular functions are overrepresented in the new mRNA targets
(Methods). Most notably, the predicted set of targets for the edited
versions of bothmiR-381 andmiR-589 exhibits overrepresentation
of neuronal functions (Methods). This finding may hint that the
editing in these twomiRNAs affects brain physiology, as previously
demonstrated for miR-376 (Kawahara et al. 2007).
A-to-I editing signal in publicly available mouse brain miRNAs
The editing detection procedure described above can be readily
used on any NGS data of mature miRNA. We used five publicly
available data sets to search formiRNA editing events in themouse
cortex, cerebellum, and hippocampus (Methods; Table 2). In
agreement with the human brain data, we see a clear A-to-I editing
signal, as 98.8% of the sequencemodifications detected are A-to-G
mismatches (Supplemental Fig. 5). Many of the detected sites are
known mouse editing sites (16/32) (Supplemental Table 7), and
many were identified in our human brain experiments above (10/
32) (Table 2). In addition, 16 novel editing sites were detected
(Methods; Supplemental Table 7). Different tissues typically show
similar editing sites. However, in a few cases the levels of editing
vary significantly between the different tissues and even between
different samples of the same tissue. For example, the editing level
of position 5 in themature sequence ofmiR-411 varies between1%
and 90% (Table 2).
Discussion
Here, we generated and analyzed data of mature miRNAs from
human brain tissues and observed a clear A-to-I editing signal, re-
vealing previously characterized editing sites as well as novel
editing sites. We have also examined a number of mouse brain
region samples. Reassuringly, all data sets yielded similar results,
providing overlapping lists of predicted editing sites. We further
validated our approach using an in vitro experimental setup in
Figure 2. Sequence preference in the bases flanking the A-to-G editing sites detected in the human brain samples (A) and themouse brain samples (C ),
in sequence Logo format (Crooks et al. 2004). (B,D) Sequence preference in the bases opposing the A-to-G editing sites for the human brain samples and
the mouse brain samples, respectively.
Alon et al.
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whichNGS data were generated fromADAR overexpression inU87
and U118 cell-lines.
Interestingly, many of the detected editing sites have relatively
low editing levels (<5%) (Table 1). It is thus possible that many of
these sites haveno biological significance, but the finding that some
of them are conserved in the mouse brain with the same level of
editing hints otherwise.One possibility is that editing sitesmight be
edited at a basal low level in generic (or pooled) tissues, being
strongly edited only in specific tissues or under specific conditions.
Indeed, our data showanumber ofmiRNAs exhibitinghigh levels of
editing in one specific brain tissue sample (e.g., miR-1251 in the
mouse cerebellum) (Supplemental Table 7).
In addition, we note that low miRNA editing level does not
necessarily mean that the editing has no biological significance.
Editing of a miRNA has two effects. One is the reduction in the
amount of the wild-typemiRNA, and the other is the introduction
of a new versionofmiRNA. A low level of editing in the recognition
site of an abundantly expressed miRNA might have virtually no
biological effect on the function of the original miRNA, due to the
small reduction in the wild-type abundance. However, even if
a small fraction of the transcripts of an abundant miRNA is edited
to become a ‘‘new miRNA,’’ with a new set of targets, this moder-
ately abundant miRNA might be functionally important. For ex-
ample, the edited version of miR-381, representing only 6% of the
wild-type miRNA count, is in the top quartile of all expressed
miRNAs (Supplemental Table 5).
Some of the editing sites detected in
mature miRNAs lie outside the recogni-
tion site. The biological significance of
these is yet to be explored. It was suggested
that these editing events may affect the
loading of thematuremiRNAs to the RNA-
induced silencing complex (RISC) com-
plex, thereby altering the effectiveness of
the mature miRNAs (Nishikura 2010).
Altogether we identified 24 editing
sites in human brain miRNAs (pooled
total brain or frontal lobe) and 32 sites in
themouse brain. It should be pointed out
that this number is rather small consider-
ing the dsRNA structure of the pri-miRNAs.
It was previously suggested that many of
the pri-miRNA editing events suppress
miRNA processing steps (Nishikura 2010).
Therefore, it is possible that many pri-
miRNAs do get edited but are then dis-
cardedanddonot result inmaturemiRNAs.
However, there are also reported cases of
pri-miRNA editing events that enhance
miRNA processing steps (Nishikura 2010).
Therefore other explanations should be
looked for, including the possibility that
the pre-miRNA export from the nucleus
is somehow suppressed by the editing
(Nishikura 2010). These possible mecha-
nisms may protect numerous genes from
being down-regulated by large number of
edited mature miRNAs.
The procedure described here allows
for a reliable detection and quantification
of A-to-I editing events using NGS data of
mature miRNAs in varying experimental
set-ups, including comparison of the editing profile between nor-
mal and pathological conditions. Such experiments will increase
our knowledge about how important is the regulation of miRNA
editing and whether its loss can be linked to certain pathologies.
Methods
Human brain miRNA sequencing
The RNA sample used was FirstChoice Human Brain Reference
RNA (Ambion AM6050), which is pooled from multiple donors
and several brain regions. All steps of the protocol for miRNA
capture and library construction were conducted according to the
method described by Alon et al. (2011). The mature miRNA library
was sequenced on one lane of Illumina GAIIx instrument following
the manufacturer’s protocol. The total number of reads was ;10
million. All the reads were filtered, demanding that the quality of
each read will not be below some threshold value (chosen to be 20)
in more than three positions. In addition, sequences identified as
59 or 39 adaptors were removed. After adaptors trimming, reads with
length longer (>28 bases) or shorter (<15 bases) than the typical
length of a mature miRNA were also removed. Approximately
5 million reads passed this filtering process.
Aligning the reads against known miRNAs
As the 39 end of mature miRNAs undergoes extensive modifica-
tions (Burroughs et al. 2010), the last two bases of the read were
Figure 3. Novel human miRNA editing sites detected in the pooled brain and frontal lobe samples
and validated using in vitro overexpression experiments in U87 and U118 cell-lines. The editing levels
in four miRNAs are shown: (A) miR-455 5pmature position 17, confirmed by ADARB1 overexpression in
both U87 and U118 cell-lines; (B) miR-421 mature position 14, confirmed by ADARB1 overexpression in
both U87 and U118 cell-lines; (C ) miR-381mature position 4, confirmed by ADAR overexpression in the
U87 cell-line; and (D) miR-497 mature position 2, confirmed by ADARB1 overexpression in the U118
cell-line. If the editing site is detected in themouse brain data of Chiang et al. (2010), the editing levels in
this tissue are also presented. The number of sequencing reads supporting the editing site is indicated on
the bar. (E,F) The predicted change in mRNA targets as a result of editing in the binding site of miR-381
and miR-497, respectively.
Systematic identification of edited microRNAs
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trimmed (Chiang et al. 2010). The filtered and trimmed reads were
aligned using Bowtie (Langmead et al. 2009) against the human
genome (UCSC hg19/GRCh37), allowing up to onemismatch.We
demanded unique best hits (i.e., reads that cannot be aligned to
other locations in the genome with the same number of mis-
matches). This step solves, by and large, the cross-mapping prob-
lem that was reported by de Hoon et al. (2010). The importance of
39 end trimming, as well as aligning the reads against the genome
andnot directly against the knownmiRNA sequences, is illustrated
in Figure 1, A through C. If we align all the untrimmed reads against
the knownmiRNA sequences, demanding unique best hits and up to
onemismatch, a considerable amount of adenylation and uridylation
events is clearly observed (Fig. 1A; Burroughs et al. 2010). When the
sameprocedure is performedwith trimmed reads (the last two bases of
the readswere removed),A-to-Gmodificationsbecomedominant (Fig.
1B). Finally, when the trimmed reads are uniquely aligned against the
genomeandnot directly to themiRNAs sequences, the cross-mapping
effect is suppressed and the A-to-G signal is enhanced (Fig. 1C).
Overall, ;1.4 million reads were successfully aligned to the
human genome.Only;1.1million reads that were aligned against
genomic regions of known pre-miRNAs, as defined in release 17 of
miRBase (Kozomara and Griffiths-Jones 2011), were further used.
Reads with a perfect match to regions of mature or star miRNAs
(according to the definitions of miRBase) were counted. In addi-
tion, reads that had only onemismatch to regions ofmature or star
miRNAs but with a high-quality score (phred score) of 30 and above
at this position were also counted. Finally, for each position in the
mature and star miRNAs, the counts (number of supporting reads)
of each sequenced nucleotide were calculated.
Estimating the sequencing error rate
The sequencing error rate was estimated using the phred score
supplied by the Illumina’s sequencer. As only mismatches with
phred score of 30 were allowed (see above), the expected base call
error rate cannot exceed 0.1% in each position. We used the
aligned read data to validate that this estimate is indeed compati-
ble with the actual sequencing error in the retained reads. By
merging the data from all the mature and star miRNAs, we calcu-
lated the rate of any type of mismatch from the 12 possible mis-
matches. In this calculation, the location of the mismatch should
also be taken into account as biologicalmodifications appear in the
39 of the miRNA (Burroughs et al. 2010) and sequencing quality is
lower toward the end of the read (Dohmet al. 2008). Therefore, the
calculation was performed separately in each position along the
mature/star miRNA. The total mismatch rate (summing all the 12
types of mismatches) was 0.1%–2.6% in the different positions.
These numbers are higher than the expected estimation from the
phred score (<0.1%). However, the rate relevant for the statistical
analysis to follow (see Identifying Editing Sites inmiRNAs below) is
the maximal mismatch rate of any single type of mismatch, not
the sum over all mismatches. Indeed, by excluding four excep-
tions, no single mismatch type had rates >0.1% at any position.
The four exceptions were all A-to-Gmodifications at positions 1, 4,
5, and 6, and they were caused by extensive A-to-G modifications
in miR-99a, miR-381, miR-411, and miR-376c, respectively (Sup-
plemental Table 5). By excluding these four A-to-G mismatches,
the total mismatch rate is lowered to 0.1%–0.29%, which is com-
patible with the rate expected according to the phred score.
Identifying editing sites in miRNAs
All the locations in each mature or star miRNA were screened for
mismatches that were overrepresented considering the expected
sequencing error rate. This was done by applying the binomial cu-
mulative distribution on the counts of each sequenced nucleotide.
The expression filter used was very permissive, taking into account
anymiRNAwithmore than five reads. Byusing aBenjamini-Hochberg
Table 2. The statistically significant A-to-Gmodifications sites detected inmaturemiRNAs from publicly available NGS of mouse brain tissues
miRNA Location
Editing levels
in mouse
cerebelluma
Editing levels
in mouse
cortexb
Editing levels
in mouse
cortexc
Editing levels
in mouse
hippo-campusd
Editing levels
in mouse
hippo-campuse
Editing
levels in
mouse brainf
Editing
levels in
human braing
miR-27a Star position 1 4.3 11.4 N.S. N.S. N.E. N.S. 20.5h,3.1i
miR-99a Mature position 1 8.1 6.7 N.S. N.S. 2.8 N.S. 5
miR-100 Mature position 1 0.3 1.4 N.S. N.S. N.S. N.S. 0.2h
miR-151 3p mature position 3 0.6 2.5 1.7 0.6 N.S. N.S. 0.6l, 1.7m
miR-376a Star position 4 7.2 4.8 15.1 9.8 N.E. 29.7 18.9j
miR-376c Mature position 6 2.6 4 1.4 N.S. N.S. 31.1 8.5
miR-379 Mature position 5 17.2 9.6 N.S. N.S. 3.5 9.5k 10.2
miR-411 Mature position 5 88 73.4 1.1 0.9 12.4 23.9 15.3
miR-421 Mature position 14 11 N.S. N.S. N.S. N.E. 5.4 1.8
miR-497 Mature position 2 0.8 N.S. 4.6 1.5 N.S. 10.4 6.2
Only sites that were also detected in the human samples (Table 1) are presented; the full list of sites is in Supplemental Table 7. The editing levels in the
edited miRNAs previously detected in the mouse brain (Chiang et al. 2010) are also presented. Sites in which the modifications were not statistically
significant are marked by N.S. Sites in miRNAs with low expression levels (10 or fewer reads) are marked with N.E. The editing levels are given in
percentage.
aSRA data set SRR346417.
bSRA data set SRR346423.
cSRA data set SRR038744
dSRA data set SRR038741.
eSRA data set SRR345196.
fChiang et al. (2010).
gFrom Table 1.
hDetected in the U118 ADARB1 overexpression experiment (Supplemental Table 5).
iDetected in the U87 ADARB1 overexpression experiment (Supplemental Table 5).
jThe equivalent of mouse miR-376a in star position 4 is human miR-376a-1 in star position 3.
kChiang et al. (2010) indicate editing in the star of miR-379, but they probably mean the mature as the star do not have A in position 5.
lDetected in the human frontal lobe, sample A (Table 1).
mDetected in the human frontal lobe, sample B (Table 1).
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false-discovery rate of 5% (Benjamini and Hochberg 1995), we
found 19 statistically significant locations (Table 1). Remarkably,
almost all the A-to-G mismatches that were recorded before the
binomial statistical test were indeed clustered to these 19 loca-
tions, whereas all the other types of modifications were filtered
out (Fig. 1C,D).
Note that the statistical significance threshold for detection
strongly depends on the number of reads available for this miRNA.
Thus, it is possible to have sites with the same level of editing in
two samples, where in one sample the modification is statistically
significant and in the other it is not.
The sequence properties of the detected A-to-G modification
sites are illustrated by the example of miR-455 (Supplemental Fig.
1) and summarized in Supplemental Table 2. Sequence preference
in the bases flanking the A-to-G editing sites detected in the hu-
man brain samples as well as sequence preference in the bases
opposing the A-to-G editing sites were created using the WebLogo
tool http://weblogo.berkeley.edu/ (Fig. 2; Crooks et al. 2004).
We note that some low-abundance isomirs display 59 sequence
modifications similar to the biological modifications reported at
the 39 of mature miRNAs (Burroughs et al. 2010). We identified 42
isomers that start one or two bases upstream of a different isomer
and display sequence modifications in the 59 end in the form of
adenylation and uridylation. In all these events, the abundance of
the modified isomer was at least two orders of magnitude lower
than the unmodified isomer. Eleven out of these 42 events were at
position 1 of the mature miRNA according to the miRBase defini-
tion (Kozomara and Griffiths-Jones 2011), and the rest were at up-
stream positions. Detailed characterization of the 39 modifications
in mature miRNAs is still in process (Burroughs et al. 2010; Wyman
et al. 2011), and it is possible that some low abundant 59 modifi-
cations also exist in mature miRNAs. Therefore, we have discarded
all these events from our analysis.
Comparison to known editing sites in mature human miRNAs
Experimentally validated editing sites in human miRNAs (Blow
et al. 2006; Kawahara et al. 2008) were examined in order to see
how many of them were detected by our method (Supplemental
Table 3). Only editing in mature and star miRNAs was included in
this comparison as our brain samples sequencing data only include
mature and star miRNAs.
In vitro overexpression experiments
The overexpression of ADAR and ADARB1 in the U87 and the
U118 human glioblastoma cell-lines was performed according to
the method described by Paz et al. (2007) and Cenci et al. (2008),
respectively (Supplemental Methods). MiRNA capturing and library
construction, for the U87 and U118 cell-lines samples, were con-
ducted using Illumina’s TruSeq Small RNA Sample Prep Kit. The
miRNAs were sequenced using Illumina HiSeq2000 instrument
(Supplemental Methods). The sequencing data were analyzed as
described above for the human brain miRNA sequencing data
(Supplemental Methods).
Human frontal lobe miRNA sequencing and analyzing
Normal frontal white matter samples, obtained from pediatric
patients undergoing focal brain resection for head injury (e.g.,
brain contusion), were used. The two frontal lobe samples (A and
B) were obtained from a 3-yr-old boy and a 3-mo-old girl, re-
spectively. MiRNAs were sequenced using Illumina HiSeq2000
instrument, and the sequencing data were analyzed as described
above (Supplemental Methods).
Analyzing publicly available mouse brain miRNAs
sequencing data
Five data sets were downloaded from the Sequence Read Archive
(SRA) (http://www.ncbi.nlm.nih.gov/sra): SRR346417, SRR346423,
SRR038744, SRR038741, and SRR345196, which contain mature
miRNA NGS reads from mouse cerebellum, cortex (first sample),
cortex (second sample), hippocampus (first sample), and hippo-
campus (second sample), respectively. These data sets were ana-
lyzed as described above (Supplemental Methods).
Functional analysis of the edited miRNAs
TargetScan (Lewis et al. 2005) was used in order to detect possible
targets of the miRNAs, before and after the editing. We used Tar-
getScanHuman 5.2 Custom (http://www.targetscan.org/vert_50/
seedmatch.html) to identify conservedmRNA targets for positions
2–8 in the mature miRNAs. Following the method described by
Kawahara et al. (2007), we approximate the set of targets for the
edited version of the miRNA by treating inosine as a guanosine.
Like guanosines, inosines bind strongly to cytidines and more
weakly to uridines. The binding energy of inosine to cytidine is
roughly the same as that of guanosine, while the binding energy of
inosine to uridine is lower than that of guanosine. On the other
hand, inosine weakly base-pairs to adenosine, while guanosine
does not (Vendeix et al. 2009). The following TargetScan estimates
should therefore be considered only as a rough estimate to the
change in miRNA specificity due to the editing event. The total
number ofmRNA targets before and after the editing was recorded,
as well as the targets overlap (Supplemental Table 6). The overlap
between the putative mRNA targets before and after the editing
was ;3% on average, meaning that editing significantly changes
the binding specificity of the miRNAs.
ThemRNA targets that were created by the editing events (i.e.,
were not detected as targets before the editing) were analyzed in
order to find overrepresented molecular functions in them. The
DAVID bioinformatics tools were used for that purpose (Huang
et al. 2009), focusing on overrepresented gene ontology (GO)
categories and KEGG pathways (Ashburner et al. 2000; Kanehisa
and Goto 2000). The DAVID’s default human genes background
was used. From the list of 18 miRNAs that were edited in their
binding sites (Table 1), six had statistically significant (Benjamini-
Hochberg corrected P < 0.05) overrepresentation of molecular
functions in their mRNA targets (Supplemental Methods). Similar
analysis was performed for the edited miRNAs detected in the
mouse brain samples (Supplemental Table 10; Supplemental
Methods).
Data access
The sequencing data have been submitted to the NCBI Sequence
Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/sra) under ac-
cession numbers SRA029326, SRA044983, and SRA049814. A de-
tailed protocol describing the editing detection scheme, including
our scripts, is given at webpage www.tau.ac.il/;elieis/miR_editing.
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